English | Español
Robert Hadley | Apr 16, 2017

XGEVA pending approval for myeloma patients
Ruth de Jauregui | Apr 14, 2017

FDA panel reviews license application for potential hemophilia B treatment
Keri Carbaugh | Apr 11, 2017

Proposed rule changes aimed at improving 2018 health insurance choices
John Breslin | Apr 11, 2017

Cancer patient advocates watch health care debate to ensure access to coverage

Ruth de Jauregui | Apr 9, 2017

Bruno Farmaceutici, Orexigen Therapeutics Ireland to distribute Mysimba in Italy
John Breslin | Apr 6, 2017

Gottlieb to Senate committee: FDA must be a 'regulatory watchdog'
Robert Hadley | Apr 5, 2017

European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Ruth de Jauregui | Apr 3, 2017

European Medicines Agency recommends Keytruda for approval

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment